Boothe Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,250
Closed -$3.89M 43
2024
Q2
$3.89M Buy
4,250
+140
+3% +$112K 1.8% 23
2024
Q1
$3.2M Sell
4,110
-5,505
-57% -$3.92M 1.61% 21
2023
Q4
$5.61M Sell
9,615
-171
-2% -$99.8K 2.53% 18
2023
Q3
$5.26M Sell
9,786
-2,568
-21% -$1.32M 2.65% 16
2023
Q2
$5.79M Buy
12,354
+17
+0.1% +$7.13K 3.07% 12
2023
Q1
$4.24M Buy
+12,337
New +$4.16M 2.26% 18

Other funds holding LLY

Boothe Investment Group's LLY Position: Q3 2024 in Review

Boothe Investment Group sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 4,250 shares — an estimated $3.89M sold.

Boothe Investment Group first reported a position in LLY in Q1 2023 and held it in 6 quarters. The position peaked at $5.79M in Q2 2023. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Boothe Investment Group reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • Boothe Investment Group sold 4,250 Eli Lilly shares in Q3 2024, an estimated $3.89M.
  • Boothe Investment Group first reported a position in Eli Lilly in Q1 2023 and held it in 6 quarters.
  • Boothe Investment Group's Eli Lilly position peaked at $5.79M in Q2 2023.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Boothe Investment Group's 13F filing for Q3 2024, filed 5 Nov 2024.